If you've spent any time in health and wellness content online over the past few years, you've almost certainly come across Gary Brecka. The biometric data analyst turned social media personality made methylation genetics accessible to an audience that had never heard of MTHFR — and in doing so, he built 10X Health into one of the more recognized names in personalized health testing. For a lot of people, 10X Health was their first introduction to the idea that a handful of specific genes could have real, practical implications for how they feel and function.
That's a genuinely good thing. Methylation genetics matter. The research is solid. And making it legible to a mainstream audience is harder than it looks.
But now that the concept has traction — and now that many of you reading this either already have 23andMe data sitting in your account or are deciding where to spend your health dollars — it's worth taking an honest look at what 10X Health actually tests, what it costs, and whether there's a better fit for where you are right now.
What 10X Health Offers and How It Became Popular
10X Health's gene test focuses on methylation: the biochemical process that drives DNA repair, neurotransmitter production, detoxification, and hundreds of other enzymatic reactions throughout the body. Gary Brecka's core argument — that a small number of genetic variants can explain a wide range of chronic symptoms, from fatigue to mood instability to cardiovascular risk — resonated because it's largely true. Impaired methylation is common, underdiagnosed, and genuinely responsive to targeted supplementation.
Brecka's social presence drove enormous awareness. Short-form clips explaining MTHFR and homocysteine reached people who had never engaged with functional medicine before. His framing was direct: you may have a gene variant that's making you feel like you're running on half a tank, and there's a straightforward fix. That message connected.
As of late 2025 and into 2026, Brecka has reportedly stepped back from his day-to-day involvement with 10X Health. The company continues to operate, and its testing service remains available. But it's worth noting the shift — part of what drew people to 10X Health was the personal brand behind it, and that dynamic has changed.
What the Test Actually Covers: Five Genes
The 10X Health gene panel tests five variants:
MTHFR — The anchor of the methylation cycle. This gene encodes the enzyme that converts folate into its active form, methylfolate. The two most clinically significant variants, C677T and A1298C, are both covered. C677T in particular can reduce enzyme activity by 30–70% depending on whether you carry one or two copies, which affects everything downstream in the methylation cycle.
MTR — Methionine synthase. This enzyme uses methylfolate and B12 together to convert homocysteine back into methionine. Variants in MTR (particularly A2756G) can impair this step, meaning homocysteine builds up even when someone is getting adequate folate.
MTRR — Methionine synthase reductase. MTRR regenerates the B12 that MTR uses. Without effective MTRR function, MTR can't keep working, and the B12-dependent arm of the methylation cycle slows down. The A66G variant of MTRR is among the more common and impactful methylation variants.
COMT — Catechol-O-methyltransferase. This enzyme breaks down dopamine, epinephrine, and norepinephrine in the prefrontal cortex. A slower COMT variant (Val158Met) means these neurotransmitters linger longer, which can mean better focus under low-stress conditions but worse performance under pressure, along with heightened sensitivity to stimulants, certain supplements, and psychological stressors.
AHCY — Adenosylhomocysteinase. AHCY controls the conversion of S-adenosylhomocysteine (SAH) to homocysteine. When AHCY is impaired, SAH accumulates — and SAH is a potent inhibitor of methyltransferase reactions throughout the body. AHCY variants are less common than MTHFR, but high-impact when present.
These five genes are legitimate and well-researched. They represent a meaningful slice of the methylation picture. The question isn't whether these genes matter — they do. The question is whether they're sufficient on their own, and whether $599 is the right price point for this specific analysis given what's already available.
The Cost Question: $599 for Five Genes
The 10X Health test costs $599. It requires a blood draw — you receive a kit, collect a sample, and send it back for lab analysis. The process takes time, requires logistics, and involves a new collection that doesn't rely on any data you may already have.
That price reflects a real service. There are people on staff, kit logistics, lab processing, and a report. It isn't a scam price. But context matters here, and the context is significant.
All five of the genes 10X Health tests — MTHFR, MTR, MTRR, COMT, and AHCY — are already present in your raw data if you've taken a 23andMe or AncestryDNA test. These consumer DNA tests use genotyping arrays that capture hundreds of thousands of SNPs across your genome, and the variants 10X Health analyzes are among the most well-studied in existence. They're covered by the major arrays. If you tested with 23andMe or AncestryDNA, you already have this data.
You just haven't had it analyzed yet.
Roughly 40 million people have taken a consumer DNA test. The majority of them have raw data files sitting in their accounts, completely untouched, containing exactly the information a methylation panel would surface — and considerably more. Paying $599 and undergoing a new blood draw to get a five-gene report on data you already own is worth pausing on.
What a Broader Analysis Looks Like
Methylation doesn't operate in a vacuum. The five genes 10X Health covers are part of a larger network, and that network connects to several other biological pathways that have equally real implications for how you supplement.
Consider what's missing from a five-gene methylation panel:
Vitamin D metabolism. The VDR gene (vitamin D receptor) determines how effectively your cells respond to vitamin D. The GC gene affects how efficiently vitamin D is transported in the bloodstream. Variants in either can mean that standard doses — even doses that produce normal blood levels — don't produce the cellular response you're hoping for. This is separate from methylation but directly affects supplement dosing.
Detoxification pathways. The CYP enzyme family handles a substantial portion of your liver's detox workload: processing medications, environmental chemicals, and hormones. CYP1A2 governs caffeine and certain hormone metabolism. CYP2D6 affects a wide range of prescription medications. CYP1B1 is involved in estrogen processing. Variants here affect which supplements support or stress your detox capacity — and they interact with the methylation picture in ways that change recommendations.
Inflammatory signaling. TNF-alpha and IL-6 are cytokines that regulate inflammatory responses. Variants in the genes controlling their production can push baseline inflammation higher than average, which affects cardiovascular health, joint function, and metabolic efficiency. The appropriate anti-inflammatory supplement support differs meaningfully based on whether these variants are present.
Cardiovascular risk. APOE status — whether you carry E2, E3, or E4 — affects how your body processes fats and cholesterol, and it's the most significant known genetic risk factor for late-onset Alzheimer's disease. This changes supplement priorities in ways that a methylation-only panel won't surface.
Additional methylation variants. Beyond the five genes 10X Health covers, there are others in the same cycle worth knowing about: CBS (cystathionine beta-synthase), BHMT (betaine-homocysteine methyltransferase), FOLR1, and others. These influence how the methylation cycle handles traffic from different directions and can shift the appropriate supplement protocol in meaningful ways.
A complete picture requires looking at all of this together — not because every variant matters equally, but because the variants interact. Your COMT status changes how you should think about methylation support. Your MTHFR status changes how you should think about B12 forms. Your detox gene profile changes how aggressively you should push certain supplements. These aren't independent questions.
What Whole Gene Health Does Differently
Whole Gene Health was built around a specific premise: most people who want this kind of analysis already have the raw data. The job is to analyze it thoroughly and translate it into something actionable.
The service accepts raw DNA files from 23andMe or AncestryDNA. If you've taken either test, you can download your raw data file — it takes about five minutes — and upload it directly. No new kit. No blood draw. No waiting for a sample to process.
The analysis covers 100+ variants across all the major pathways: methylation (including all five genes 10X Health covers, plus additional variants), detoxification, vitamins, neurotransmitters, inflammation, cardiovascular, and antioxidant defense. Each variant is interpreted in the context of the others — not as isolated data points, but as a system.
The output is a personalized supplement protocol. Not a data dump of variant statuses with academic footnotes, but specific recommendations: which supplements, what forms (methylfolate vs. folic acid, methylcobalamin vs. cyanocobalamin), what doses adjusted for your body weight and age, what timing (certain supplements are more effective taken in the morning; others are better in the evening), and specific product recommendations by brand. The report also screens for interactions with any medications you're currently taking.
The price is $249.
The comparison: $599 for five genes via a new blood draw, versus $249 for 100+ genes from data you likely already own. The price-to-depth ratio isn't close. But the right choice still depends on your situation.
Who Should Still Consider 10X Health
This isn't a case for dismissing 10X Health categorically. There are real reasons someone might choose their service:
You haven't taken a consumer DNA test. If you don't have 23andMe or AncestryDNA data and have no interest in taking either test — perhaps due to privacy concerns about storing DNA with a large consumer company — then the raw data advantage doesn't apply. 10X Health's blood-based test gives you a methylation panel without requiring you to go through a consumer genetics company first.
You want a clinician-guided experience. 10X Health's model includes practitioners who can interpret results and make recommendations in a medical context. If you want to go through results with a clinician and have that conversation built into the service, that has value. Whole Gene Health provides a thorough written protocol, but it's a self-directed product rather than a supervised clinical engagement.
You specifically want blood-based testing. Some people prefer lab-confirmed blood tests for health data, regardless of the cost difference. That's a legitimate preference.
Both services are operating in good faith on a real scientific foundation. This isn't a situation where one option is fraudulent and the other isn't. It's a situation where the value proposition differs significantly depending on what you already have and what you're trying to accomplish.
The Methylation Genes Are the Starting Point, Not the Full Story
One of the things that's happened as methylation genetics entered mainstream health culture is that MTHFR became a kind of shorthand — the gene that explains fatigue, mood instability, and a feeling that nothing works. For some people, that framing is roughly right. For many, it's incomplete in ways that matter.
Someone can be MTHFR C677T homozygous, take methylfolate and methylcobalamin, and still feel off — because their MTRR A66G variant means the B12 regeneration step is also impaired, or because their COMT Val158Met status means that aggressive methylation support produces overstimulation rather than resolution, or because their CYP detox variants mean they're accumulating something that methylation support alone can't clear.
These aren't rare edge cases. They're common enough that a narrow panel produces incomplete guidance for a meaningful share of the people who use it. The fix isn't to abandon methylation genetics — it's to look at the full context.
That context lives in your raw data. If you've already done a 23andMe or AncestryDNA test, you have everything you need to get a complete picture. The five genes 10X Health charges $599 to analyze are a subset of what's already there, waiting.
Making the Right Call for Your Situation
If you're someone who has been considering 10X Health because you saw Gary Brecka's content and wanted to understand your methylation genetics, the underlying goal is sound. This is worthwhile information. It's information that can change which supplements you take, which forms you use, and in some cases, how you understand symptoms you've been managing for years.
The question is how to get that information most effectively. If you already have a 23andMe or AncestryDNA result, those five methylation genes are already in your account. A service that analyzes those five genes plus 95 more — using data you already own — for less than half the price is worth a serious look before you send a blood draw kit back to anyone.
If you don't have existing DNA data and want a blood-based panel with clinical support, 10X Health remains a reasonable option for the five genes it covers. Go in knowing the scope is narrow and that a more complete picture exists.
Either way, understanding your methylation genetics is a step worth taking. The specifics of how you take it — and how much you spend — should match where you're starting from.